{
    "2021-10-24": [
        [
            {
                "time": "",
                "original_text": "西部证券维持通策医疗买入评级：20Q3高基数下21Q3增长符合预期，蒲公英计划快速推进",
                "features": {
                    "keywords": [
                        "通策医疗",
                        "买入评级",
                        "20Q3",
                        "21Q3",
                        "增长",
                        "蒲公英计划"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}